Literature DB >> 48853

Letter: Dapsone in Crohn's disease.

M Ward, J P McManus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 48853     DOI： 10.1016/s0140-6736(75)92216-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  The inhibition of polymorphonuclear leukocyte cytotoxicity by dapsone. A possible mechanism in the treatment of dermatitis herpetiformis.

Authors:  O Stendahl; L Molin; C Dahlgren
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

Review 2.  Antibacterial therapy for Crohn's disease: a review emphasizing therapy directed against mycobacteria.

Authors:  K Hultén; A Almashhrawi; F A El-Zaatari; D Y Graham
Journal:  Dig Dis Sci       Date:  2000-03       Impact factor: 3.199

3.  In vitro and in vivo effects of dapsone on neutrophil and lymphocyte functions in normal individuals and patients with lepromatous leprosy.

Authors:  R Anderson; E M Gatner; C E van Rensburg; G Grabow; F M Imkamp; S K Kok; A J van Rensburg
Journal:  Antimicrob Agents Chemother       Date:  1981-04       Impact factor: 5.191
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.